Nervgen Pharma Corp Stock Price on September 13, 2024

NGENF Stock  USD 1.87  0.05  2.60%   
If you're considering investing in NervGen OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of NervGen Pharma stands at 1.87, as last reported on the 27th of November, with the highest price reaching 1.93 and the lowest price hitting 1.87 during the day. NervGen Pharma Corp has Sharpe Ratio of -0.0199, which conveys that the firm had a -0.0199% return per unit of risk over the last 3 months. NervGen Pharma exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NervGen Pharma's Risk Adjusted Performance of 0.0136, downside deviation of 4.93, and Mean Deviation of 3.11 to check out the risk estimate we provide.
  
NervGen OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0199

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNGENF

Estimated Market Risk

 4.73
  actual daily
42
58% of assets are more volatile

Expected Return

 -0.09
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average NervGen Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NervGen Pharma by adding NervGen Pharma to a well-diversified portfolio.

NervGen Pharma Valuation on September 13, 2024

It is possible to determine the worth of NervGen Pharma on a given historical date. On September 13, 2024 NervGen was worth 1.87 at the beginning of the trading date compared to the closed value of 1.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NervGen Pharma otc stock. Still, in general, we apply an absolute valuation method to find NervGen Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NervGen Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NervGen Pharma's related companies.
 Open High Low Close Volume
  1.90    1.95    1.84    1.86    63,900  
09/13/2024
  1.87    1.92    1.86    1.88    66,200  
  1.86    1.94    1.86    1.94    3,900  
Backtest NervGen Pharma  |  NervGen Pharma History  |  NervGen Pharma Valuation   PreviousNext  
Open Value
1.87
1.88
Closing Value
16.06
Upside

NervGen Pharma Trading Date Momentum on September 13, 2024

On September 16 2024 NervGen Pharma Corp was traded for  1.94  at the closing time. The highest daily price throughout the period was 1.94  and the lowest price was  1.86 . The daily volume was 3.9 K. The net trading volume on 09/16/2024 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 3.19% . The trading delta at closing time to current closing price is 5.85% .

NervGen Pharma Corp Fundamentals Correlations and Trends

By evaluating NervGen Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NervGen Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NervGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About NervGen Pharma OTC Stock history

NervGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NervGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NervGen Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NervGen Pharma stock prices may prove useful in developing a viable investing in NervGen Pharma
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.

NervGen Pharma OTC Stock Technical Analysis

NervGen Pharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of NervGen Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NervGen Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

NervGen Pharma Period Price Range

Low
November 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

NervGen Pharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

NervGen Pharma November 27, 2024 Market Strength

Market strength indicators help investors to evaluate how NervGen Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NervGen Pharma shares will generate the highest return on investment. By undertsting and applying NervGen Pharma otc stock market strength indicators, traders can identify NervGen Pharma Corp entry and exit signals to maximize returns

NervGen Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NervGen Pharma's price direction in advance. Along with the technical and fundamental analysis of NervGen OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NervGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for NervGen OTC Stock analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities